|
|
||||||||
|
Plant Physiol, May 2000, Vol. 123, pp. 17-28 Crop Biotechnology. Where Now?IACR-Rothamsted Experimental Station, Harpenden Herts AL5 2JQ, United Kingdom
Nature Biotechnology organized a conference in London on Agbiotech 99: Biotechnology and World Agriculture (November 14-16, 1999). The conference focused entirely on crop biotechnology and covered both societal and scientific aspects. Below is an account of the more important issues raised by the speakers and the audience.
General Societal Issues Western Europe has become resistant to food produced from genetically modified (GM) crops. Almost all of the European supermarket chains have removed GM crops from their own brands. There have been extremely active protests from a number of non-governmental organizations, including Greenpeace, Friends of the Earth, and Christian Aid. The EU and its member states are backing down from the approval of GM crops. The protests are spreading around the globe to the U.S. (Fig. 1) and other actual or potential producer countries. The conference tried to identify some of the causes for this.
Sir Robert May (Office of Science and Technology, London; for
detailed views of May and the Office of Science and Technology on GM
crops, see www.dti.gov.uk/ost/ostbusiness/index.htm) pointed out a
taxonomy of his concerns, the major ones being food safety, transfer of genes from crops to wild species through
cross-hybridization, and the effect of crop husbandry on impoverishing
the countryside. The general agreement from critics and
proponents alike was that, although there is a need to be careful,
there are no major concerns about food safety of GM products,
and that the U.K., the U.S., and other countries have put into place
effective regulatory procedures that are much more rigorous for GM than
for non-GM foods. For some crops in some regions (but not for a whole
range of others such as wheat, maize, and rice, over most of their
global distribution), cross-hybridization of crops with wild species
does occur. This occurs for both GM and non-GM versions Benedict Haerlin (Greenpeace, Berlin) outlined the reasons why Greenpeace opposes the introduction of GM crops. These include issues related to politics and to our scientific knowledge about the crops. He expressed concern that genetic engineering creates unprecedented new genetic life forms, that genetically modified organisms (GMOs) cannot be recalled, that DNA exchange is not understood, and that the long-term evolutionary effects of introducing GMOs were unknown. He proposed that we proceed on the basis of what is not known rather than what is, and invoked the strictest use of the precautionary principle. Although he did not wish to say that Greenpeace would never accept GMOs, the organization has such a long list of questions that he saw little chance of these being satisfied in a decade or two. How many of these questions can ever be answered without large-scale experimental field releases, which Greenpeace also opposes, is completely unclear. He expressed the view that the problems of GM crops and agriculture should not be left for technocrats to solve. Rather, Greenpeace feels that the big picture is political. Its concerns are the industrialization of agriculture, the movement of people from rural to urban areas, unlimited growth rather than sustainable growth, public good versus private business, and genetic engineering allowing agrochemical companies to "mutate" into life science companies. However, it was not clear that GMOs have had much to do with many of these issues, most of which predate the technology. In contrast, I and many others think that GMOs have the promise to address some of the real concerns raised by Greenpeace and others. Greenpeace clearly believes that the majority of the public is of its opinion. It was therefore welcome that Richard Braun (BIO-LINK, Worb, Switzerland) was present to describe the Swiss experience and the results of the one democratic vote on biotechnology, which resulted in a large majority favoring the continuation of biotechnology in Switzerland. This was due in large part to the scientists eventually waking up to the need to engage the public in a debate and even to take to the streets to demonstrate their convictions. Braun emphasized that the dichotomy between the apparent distrust of science and the continued improvement in human well-being needs to be countered by scientists making a more active contribution to the social debate. Robert May pointed out that the practice of agriculture had often been bad news for the rest of the natural world, and that we need to take care that GM crops do not make this worse. Brian Johnston (English Nature, Tauton, UK; www.english-nature. org.uk) developed this theme in more detail. He listed a range of concerns relating to GM crops that are cross-fertile with weed species or tolerant to wide spectrum herbicides. However, he emphasized that there is the potential to develop GM crops that would contribute to a more sustainable agriculture. The problem may turn out to be that developing such crops may not provide commercial profit and therefore would need to be developed with public money. Undoubtedly, there is concern that this powerful technology is being used to further commercial aims at the expense of the public good. As May said, the first Green Revolution was achieved by the non-profit sector, but this one is being achieved by industry. The challenge will be to see that the potential public benefits of the technology are delivered in both the developed and developing world, even where they do not provide an attractive target for commercial research. Although much discussed during the 3 d of the conference, this issue was not resolved. In any event, success is likely to depend on sufficient funds being made available to public sector research organizations and on technology transfer from multinational companies to the public sector. No technology is perfect, and the benefits and drawbacks of every
technology are relative. GM crops need to be judged against the
conventional technology they replace. Ben Miflin (IACR-Rothamsted) summarized some of the first analyses of the effect of GM crops in
cultivation in the U.S. Surveys over time and place do not make direct
comparisons of GM and non-GM crops. However, growers of GM cotton
containing a gene for an insecticidal toxin derived from Bacillus
thuringiensis (Bt) use one-half as much insecticide as growers of
conventional cotton. It has been estimated that total insecticide use
in cotton in 1998 was around 1,000 tons less than that used before Bt
cotton was introduced (James, 1998 Scientists are also not immune from neglecting to carry out the
appropriate comparisons. The work of Losey et al. (1999) The introduction of GM crops has also led to entirely new approaches to
the commercial launching of a pesticide product. The requirements of
producers and farmers to develop and implement strategies to combat the
development of insect resistance to Bt crops is, as Denholm argued, a
very significant step forward in resistance management. Such a
requirement is not in force for conventional insecticides nor for
the use of organic Bt sprays (for recent developments in requirements
for refugia, see www.epa.gov/pesticides/biopesticides). The
development of new insecticidal principles and their deployment in
crops offers further opportunities for overcoming resistance (Schuler
et al., 1998 Developing Countries There was widespread discussion on the application of
biotechnology in developing countries. Most people agreed with the
recent conclusion of the Nuffield Council on Bioethics that "The
moral imperative for making GM crops readily and economically available to developing countries who want them is compelling"
(www.nuffield.org/bioethics/publication/modifiedcrops/rep0008132.html). Unfortunately, as one of the speakers pointed out, the invited speakers
on this topic were middle-aged white men from the West. If another
conference is convened, the organizers should address this lack of
balance (for the views of a female African scientist, see Wambugu,
1999 The facts were communicated well by several speakers. The world's population, which reached 6 billion in October 1999, is estimated to reach around 8 billion in 2020; the majority of this increase is likely to occur in the cities of the developing world. Currently, there is around 0.25 ha of agricultural land per person in the world; however, whereas a Kenyan uses 0.1 ha, a Canadian has around 1 ha. By 2020, the world average will be down to about 0.17 ha. Despite improvements over the last 50 years, some 800 million people have insufficient food, and over a billion people, particularly women and children, are affected by specific nutrient deficiencies (iron, vitamin A, etc.) (www.fao.org; www.unfpa.org). Although the world may be able to produce enough food, particularly if
Eastern Europe and the former Soviet Union make full use of their
agricultural resources, the problems of politics, poverty, and
distribution are still likely to prevent the needy from being fed. As
Willy De Greef (Novartis Seeds, Basel) emphasized, there needs
to be a distribution of technical knowledge to enable and enhance
production close to the centers of need. The Consultative Group
on International Agricultural Research (CGIAR) institutes (www.cgiar.org) have been very successful (but not sufficiently) in
doing this in the past with the first Green Revolution. Gordon Conway
(Rockefeller Foundation, New York) made his well-known case for a
second Doubly Green Revolution (Conway, 1999 There was general agreement that the needs of the developing world
probably will not be addressed by commercial organizations. This is
especially true for those crops that are of minor importance in the
West. However, multinationals can play an important role in the
transfer of technology to the CGIAR institutes or to national governments via organizations such as ISAAA (www.isaaa.org). There are
already success stories in which such transfers have taken place and
some crops are already in commercial production, but more needs
to be done (James, 1997
Crop Protection Most of the GM crops in production at the moment have
modified crop protection characteristics, chiefly protection against insects and from competition (herbicide tolerance). While there are
some commercial virus resistant crops, there are further possibilities for improvement, especially in relation to the plant diseases that
prevail in developing countries. Progress, particularly in using
pathogen-derived resistance, was reviewed by Roger Beachy (Donald
Danforth Plant Science Center, St. Louis; Beachy, 1997 Whereas agrochemicals have been successfully used against biotic
stresses, they have had little effect in protecting crops against
abiotic stresses. There are indications that biotechnology may be more
suited to achieve this goal. One of the widest ranging stresses in
world agriculture is pH, with some 40% of arable land being too acidic
and another 20% too alkaline for optimal crop production. Acidic soils
lead to metals such as aluminum becoming toxic, and to nutrients such
as phosphate becoming deficient. Herrera-Estrella described an approach
to engineering stress resistance based on the observation that certain
acid-tolerant plants excrete organic acids that chelate and trap
aluminum in the rhizosphere (De la Fuente-Martinez and
Herrera-Estrella, 1999 Water is probably the crop resource that is in shortest supply and this
condition will worsen. In addition, the quality of the water used for
irrigation will decline because of a greater salt load. Because plants
need to have their stomata open to take up CO2
for carbon fixation, they lose water continuously through transpiration. This water needs to be replaced by the uptake of water
from the soil. Can plants be created that lose less water in times of
water deficit and yet carry out photosynthesis and grow? Julian
Schroeder (University of California San Diego, La Jolla, CA) discussed
research elucidating the genetics of some of the steps in the opening
and closing of stomata. Stomata are regulated by major signal cascades
involving abscisic acid, cytosolic calcium, protein kinases and
phosphatases, potassium channels, and farensyl transferase (Ichida et
al., 1997 End-Use Qualities The recent development that was most widely mentioned during the
conference was that of the
Iron deficiency has also been approached by a multigene strategy in which genes for phytase, ferritin, and a Cys-rich metallothionin-like protein were transferred and expressed in rice endosperm. Current lines have around twice as much iron as the wild type. This modified rice now has to go through the normal biosafety and agronomic tests prior to release into Asian fields. These are significant hurdles. However, there may be more obstacles, as de Greef noted that the EU rice buyers, who buy only a small proportion of Thai rice, had notified Thailand that its rice risked rejection if any of it was found to contain GM material. Thus, the EU and the powerful multinational buyers of cereals are exerting pressure that could block the introduction of what he described as "one of the most significant biotechnological developments of the last decade." The major harvested products of plants are polysaccharides,
particularly starch. Lothar Willmitzer (Max Planck Institute of Molecular Plant Physiology, Golm bei Potsdam, Germany) discussed approaches he and his colleagues have taken to modify carbohydrate metabolism. They have made transgenic plants that produce modified starches that might be useful in industry. Producing such starches in
plants removes the need for certain chemical modifications that have
environmental side effects (Lloyd et al., 1999 Biopharming is a term used to describe the use of transgenic plants to
produce pharmaceuticals. Mitch Hein (EPIcyte Pharmacetical, San Diego,
CA) described the production of antibodies in plants. The first success
led to the synthesis in tobacco leaves of antibodies effective against
dental caries. Subsequently, it has been possible to synthesize
high-affinity monoclonal secretory antibodies that can prevent
microbial infection in humans. The technology can thus be considered
for other immunotherapeutic uses, especially in mucosal tissue (Ma et
al., 1999 Improved Transformation Although there have been a range of commercially successful
transgenic crops, the technologies used for transformation have been
relatively crude. There is a need to improve the efficiency of
transformation, to limit the presence of unnecessary genes in the
products, to direct insertion to specific sites, and to give more
control over when, where, and how much expression of the transgene
occurs. Not all of these topics were addressed, but Nam-Hai Chua
(Rockefeller University, New York) described improvements in
transformation based upon the utilization of genes promoting endogenous
hormone production under the control of chemical signals. One system
uses the ipt (isopentenyltransferase) gene from the Ti
plasmid of Agrobacterium tumefaciens to increase cytokinin levels, leading to the generation of shoots from transformed plant cells (Kunkel et al., 1999 Pal Maliga (Waksman Institute, Rutgers University, Piscataway, NJ)
pointed out that using the plastid genome as a site for transgenes has
several advantages over the nuclear genome. These include transfer of
the genes only via the female line (for many but not all plant
species), thus preventing the movement of the transgene to wild species
via pollen; very high levels of expression (so far up to 20%-25% of
total cellular protein); and targeted homologous recombination into the
plastid genome. The technology is challenging and only works routinely
with tobacco, although Maliga is optimistic that it will soon work well
in rice (Maliga and Nixon, 1998 Markers and Crop Improvement by Non-Transgenic Methods Recombinant DNA technology has given rise to a range of methods
that allow the genome to be tagged with DNA markers (Karp et al., 1997 The practical value of marker technology was exemplified by the talk of
Susan McCouch (Cornell University, Ithaca, NY), in which she described
an experiment done with rice involving scientists in many centers in
different countries, which was designed to discover quantitative trait
loci important in crop performance and to recombine favorable alleles
at those loci. Oryza rufipogon, a wild relative of rice, was
crossed with three elite cultivars adapted to different growing
environments in China, Korea, and Columbia, and 300 backcross lines
were derived. These lines were tested in a wide range of environments
and evaluated for 12 key agronomic traits. Several lines showed
superior performance to the parents (Xiao et al., 1998 The Big Problem/Opportunity Tremendous opportunities for crop improvement are likely to arise
as a result of the complete sequencing of plant genomes. This is well
under way and due to be completed soon for Arabidopsis (Lin et al.,
1999
Geoffrey Duyk (Exelixis Pharmaceuticals, San Francisco) outlined some general approaches to the problem both from a broad life science perspective and from the perspective of his own company. The innovative drive of the technology is important in that it has already reduced the cost of sequencing 10-fold since the beginning of the human genome project, and Duyk expects another 10-fold reduction in the future. Automated, high-capacity technologies and informatics have been recruited to the biological research laboratory to deal with the sequence information generated and the opportunities that it presents. His view is that this is leading to a shift in the paradigm of research as the gathering and presentation of data has become an end in itself, resulting in a dissociation of data acquisition from classic hypothesis-based research. As this process gains speed, many more genomes, particularly of important pests and pathogens, will be targeted. Exelexis is particularly focused on insects and nematodes in the hope of aiding the discovery of novel insecticides and nematocides. John Ryals (Paradigm Genetics, Research Triangle Park, NC) discussed his company's approach to identifying new target sites to aid in the discovery of crop protection chemicals based on high-throughput DNA sequencing, high-throughput reverse genetics, and knowledge-based computer systems. Reverse genetics is based on generating transgenics overexpressing cDNAs in the sense and antisense orientation, and then analyzing their phenotype. The generation of mutants by this or any other approach (such as tagging) is likely to be one of the limiting steps. Phenotypic analysis will be automated as far as possible. The approach is to generate and digitize images of the plants, to conduct biochemical profiling via HPLC/mass spectroscopy for around 5,000 molecules of under 5,000 D, and to interrogate the database iteratively. This is likely to generate huge amounts of data that will need to be stored and accessed. A primary focus is thus on data management. It is estimated that 10 terabytes will be generated in the analysis of Arabidopsis. Such a program needs a large amount of resources focused on the ultimate objectives. Although the major multinationals were not represented at the conference, it is likely that similar resource-intensive approaches are being used by them. An alternative company approach was described by Guy della-Cioppa
(Genomics Biosource Technologies, Vacaville, CA). His company has
developed a plant expression system based on RNA viruses such as the
tobacco mosaic virus (Kumagai et al., 1995 The major public sector initiatives were represented by Michel Caboche
(Institut National de la Recherche Agronomique, Versailles, France).
Unfortunately, for various reasons there were no speakers from the U.S.
or other European countries. France has set up the Genoplante project.
This is a 5-year scientific program, involving private and public
laboratories and funding, which will share resources and data. So far,
around 80 projects have been funded. The goal of the project is to find
a way to co-operate with other genome projects. Its main goals are to
develop expertise, infrastructure, and competitiveness in plant genome
analysis. The program has two components, a generic part that focuses
on model genomes (Arabidopsis and rice), and a more commercial part
that will analyze the genomes of major crops (wheat, maize, oilseed
rape, and sunflower) and their syntenies with the model species. The
program aims to identify genes and alleles useful for molecular
breeding by positional cloning and candidate gene approaches. Caboche
sees the commercial approach generating industrial property rights and
new biotechnology companies, but the program does not include the
generation of GM crops. Results from the generic part will be published
and placed in a Genoplante database. Within the Arabidopsis program, the French projects (Camilleri et al., 1998
Science and Society It is my opinion that plant research is vital for the future of a world in which the human species has to reach a balanced and sustainable relationship with the rest of nature and its environment. We are increasing in population and this population is likely to have higher expectations in food provision and in longevity. All of this means a rapid increase in the demand for food, feed, fiber, and fuel. On the other side of the equation, we are rapidly depleting our fossil fuel reserves, and there are severe limitations on the amount of land and water available for agriculture. In addition, political problems and distribution costs suggest that we need, as far as is possible, to enable the bulk of food to be produced close to where it is needed. Eventually, if that does not happen, the hungry will move in large numbers to where there is food. The political and social consequences of a failure to meet the legitimate demands of the developing world will eventually be serious for the developed world. There is a view that, since the West is chiefly suffering from too much rather than too little food, it can afford to put biotechnology aside and GM crops could only be used in the developing world. There are a number of dangers in this. First, there is the argument of resource efficiency: using more land, materials, and energy than we need to produce food is a misuse of resources. Second, the technology and know-how are being developed with commercial and public resources in the West, and if the technology is blocked, the flow of funds for research will inevitably diminish severely as shareholders and the public ask why money should be spent on developing this apparently unwanted technology. Third, the food supply chain is international and the decisions as to what is grown are taken by a few people in charge of the major supermarkets and commodity traders; they are more likely to support a GM-free chain for the richer customers rather than a special GM chain for the poorer customers. Finally, globalization of pressure groups is leading to universal opposition to GM crops. Thus, there is a danger that the research and development of solutions that GM crops could provide will slow or stop, despite the needs of millions of people for sufficient locally produced food. In the words of de Greef, "a food shortage caused by an empty R&D pipeline in the long-term is lethal, preventable, and immoral." The conclusion of Braun and others is that, if scientists believe in
the importance of their research and the technologies deriving from
them, then they have to engage in the political process, to confront
the challenges of the Green activists, to engage society in the debate,
and, if necessary, take to the streets with banners. Because the
outcome will most affect the young scientists, their careers, and their
dependents, and because they are the ones most likely to be acceptable
to society (Farmelo, 2000 Crop Improvement The scientific goal for biotechnology and world agriculture is the
improvement of the genetics of our crops. The big challenge for
biological research in general, and crop improvement in particular, is
how to get the most valuable knowledge the quickest from the explosion
in DNA sequence information. A large-scale genomics approach is chiefly
being followed in industry, but to some extent is also being tried in
national and international programs. It will undoubtedly yield many
benefits, but also has many limitations. It tends to be driven by data
rather than hypotheses (see Duyk's comments above), which means that
it may be linear and unprioritized (i.e. start with the first available
sequence and work out the function of the genes one by one). It also
faces difficulties in that many important crop traits depend on the
interaction between a number of genes or may be encoded by multiple
copies of the same gene. In addition, plants are renowned for their
ability to compensate physiologically. Thus, generating large
populations of plants in which single genes are either knocked out or
overexpressed is unlikely to reveal the genetics of processes subject
to these phenomena; generating multiple combinations will probably be
numerically impossible. Even when the function of a gene sequence has
been correctly identified, there remains the problem of finding the better or best alleles. For these reasons, I have argued elsewhere that
the current thrust, which is largely based on a genocentric view, needs
to be balanced by a matching emphasis on a phenocentric approach
(Miflin, 2000 A phenocentric view of crop improvement starts from the viewpoint that
farmers cultivate phenotypes, i.e. crop performance is determined by
the interaction of genotype and environment. While the farmer can do
something to ameliorate the environment, crop improvement mainly
depends on plant breeders assembling the best combination of alleles of
the genes governing the key traits. The modified varieties are then
widely tested to determine to which environments they are adapted. The
development of marker technology, as exemplified in the work presented
by McCouch, has now opened up the ability to identify many of the loci,
genes, and alleles that are most important in crop improvement. It
allows interactions between genes to be identified and it enables the mining of new favorable alleles from wild sources. Its crucial limitation is the ability to measure the phenotypic trait sufficiently reliably and accurately. It is also dependent on the existence of
sufficient variation in the genetics of key traits in crossable species; where there is no difference between alleles at a locus, the
importance of that locus in the process is unlikely to be revealed
(e.g. the genes important in determining the rate of photosynthesis in
wheat, in which there is little variation; Evans, 1993 Physiology and biochemistry provide the third approach to
identifying genes for crop improvement. In some cases, knowledge of
biochemical pathways can lead to the identification of candidate genes,
and the subsequent transgenic plants behave as expected (see the
developments described by Herrera-Estrella and Potrykus). In contrast,
most of the developments in trying to change carbohydrate metabolism
(as described by Willmitzer) have led to the conclusion that we did not
understand the biochemistry as well as we thought we did, or that
compensation overrides the genetic changes. Nevertheless, much useful
information has been gathered and, slowly, useful changes are being
achieved. Sound physiological knowledge can also be highly useful in
developing screens to probe the many populations of sequence-defined
mutants that are being generated. An example of this in the past is the
success of the screen devised by Somerville and Ogren (1979)
I am grateful to the Lawes Agricultural Trust for their support. I appreciate the large and varied inputs into this article by the speakers and the participants of the conference; because of space I have not been able to cover the talks of all of the presenters nor to attribute all of the thoughts to their originators. Also, I may have re-interpreted verbal comments in ways that the speaker would not have done. For any such sins of omission or commission, I apologize and take ultimate responsibility for the views presented.
Received February 15, 2000; accepted February 15, 2000. * E-mail ben.miflin{at}bbsrc.ac.uk; fax 44-1582-760981.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ASPB Publications | PLANT PHYSIOLOGY® | THE PLANT CELL | |
|---|---|---|---|